Gluten Intolerance Treatment Market

Gluten Intolerance Treatment Market (Drug Type: Antihistamines and Epinephrine; Indication: Celiac Disease, Dermatitis Herpetiformis, Depression, and Gluten Ataxia) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

Gluten Intolerance Treatment Market Outlook 2034

  • The global industry was valued at US$ 593.5 Mn in 2023
  • It is expected to grow at a CAGR of 13.9% from 2024 to 2034 and reach US$ 2.5 Bn by the end of 2034

Analyst Viewpoint

The global gluten intolerance treatment market is slated to grow on the basis of increase in incidence of celiac diseases followed by rising awareness amongst the population about the importance of early diagnosis regarding intolerance to gluten.

Intake of a gluten-free diet is the only course of treatment in the present scenario, though research is being conducted regarding therapeutics on this count.

The companies operating in the gluten intolerance treatment market are collaborating with the government and non-government agencies to create awareness about the ill-effects of ignoring the symptoms of gluten intolerance. They are trying to reach out to the untapped geographies to have a wider consumer base under the belt.

Gluten Intolerance Treatment Market Overview

Gluten is a protein found in rye, barley, and wheat. In case of certain individuals, immune reaction to consumption of gluten means inflammation that destroys the lining of small intestine, thereby leading to various medical complications. It also averts the absorption of certain nutrients, which is called malabsorption).

The major symptom of gluten intolerance is diarrhea. The others include fatigue, bloating, and anemia. At times, there are no noticeable symptoms. Some people may also suffer from depression, with 20% of adolescents and young adults showing prevalence.

As of now, the major course of treatment is consumption of gluten-free diet, which can aid in managing symptoms and promoting intestinal healing.

Attribute Detail
Market Drivers
  • Growing Prevalence of Celiac Diseases
  • Increase in Awareness Regarding Early Diagnosis

Rise in Incidence of Celiac Diseases Propelling Celiac Disease Treatment Landscape

Celiac disease is amongst the common life-long disorders prevalent across the globe. The prevalence generally ranges between 0.7 and 2.9% of general population as per the National Institutes of Health.

The well-defined risk groups constitute relatives of the affected individuals and those with autoimmune comorbidities.

Research states that the symptoms of celiac disease generally subside with intake of gluten-free diet. For majority of people, following gluten-free diet heals damage in small intestine. The intake of wheat, barley, rye, and kamut and triticale thus needs to be avoided.

Need to exercise control over celiac is catalyzing the gluten intolerance treatment market.

Growing Awareness Regarding Early Diagnosis Driving Demand for Gluten Intolerance Remedies

Gluten intolerance means that one gets sick after consuming gluten (a kind of protein). He/she may also feel bloated, nauseous, or tired.

Gluten intolerance is also termed as non-celiac gluten sensitivity (NCGS). This ailment is more common in women. Some people are born with it, whereas some develop it later in their lives. Research states that 6% of the individuals based in the U.S. suffer from gluten intolerance.

Gluten intolerance, if diagnosed early, can eliminate the risk of developing complications such as thyroid. Moreover, the symptoms can range from weight gain, constipation, diarrhea, and weight loss to migraines.

Various awareness programs are being conducted in this regard, so that people can be absolved of the dire consequences of gluten intolerance.

For instance, the Gluten Intolerance Group (GIG), since 2005, has been leading the gluten-free food safety initiative, wherein it is working with the manufacturers as well as food service operators around the world to ascertain that safe, gluten-free food is served. It is a part of Chef to Plate (CTP) program.

Regional Outlook

Attribute Detail
Leading Region North America

As per the latest gluten intolerance treatment industry analysis, North America dominated the gluten sensitivity management landscape in 2023 and the scenario is expected to remain unchanged during the forecast period. This is attributed to higher rate of diagnosis of gluten intolerance followed by growing demand for advanced-level treatment.

Asia Pacific’s significant gluten intolerance treatment market growth is due to increase in healthcare expenditure by the government as well as non-government agencies to combat celiac disease.

Analysis of Key Players

The key players in gluten intolerance treatment market are conducting an extensive research regarding devising solutions for non-celiac gluten sensitivity.

For instance, AMYRA’s AMYNOPEP01 is an exclusive combination of exopeptidases, which has the capacity to cleave immunogenic polypeptide chains into dipeptides and single amino acids, which are categorized as safely metabolized digestion products not triggering immune responses.

Precigen ActoBio, Calypso Biotech SA, Alvine Pharmaceuticals, Inc., ImmusanT, Artielle ImmunoTherapeutics, FunZyme Biotechnologies, Innovative BioPharma, AMYRA Biotech AG, Vactech Composites Pvt. Ltd., Alba Therapeutics Corporation, PvP Biologics, Inc., and others are some of the key players covered in the gluten intolerance treatment market report.

These companies have been profiled based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.

Latest Developments

  • In December 2023, Amgen filed a patent that describes method to treat celiac disease, also called non-celiac gluten sensitivity using an antigen-binding fragment or anti-IL-15 antibody.

Gluten Intolerance Treatment Market Snapshot

Attribute Detail
Market Size in 2023 US$ 593.5 Mn
Market Forecast (Value) in 2034 US$ 2.5 Bn
Growth Rate (CAGR) 13.9%
Forecast Period 2024-2034
Historical Data Available for 2020-2022
Quantitative Units US$ Mn/Bn for Value
Market Analysis It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.
Competition Landscape
  • Market share analysis by company (2023)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format Electronic (PDF) + Excel
Market Segmentation
  • Drug Type
    • Antihistamines
    • Epinephrine
  • Indication
    • Celiac Disease
    • Dermatitis Herpetiformis
    • Depression
    • Gluten Ataxia
  • Distribution Channel
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • South Africa
  • GCC
Companies Profiled
  • Precigen ActoBio
  • Calypso Biotech SA
  • Alvine Pharmaceuticals, Inc.
  • ImmusanT
  • Artielle ImmunoTherapeutics
  • FunZyme Biotechnologies
  • Innovative BioPharma
  • AMYRA Biotech AG
  • Vactech Composites Pvt. Ltd.
  • Alba Therapeutics Corporation
  • PvP Biologics, Inc.
  • Others
Customization Scope Available Upon Request
Pricing Available Upon Request

Frequently Asked Questions

How big was the global gluten intolerance treatment market in 2023?

It was valued at US$ 593.5 Mn in 2023

How is the gluten intolerance treatment business expected to grow during the forecast period?

It is projected to grow at a CAGR of 13.9% from 2024 to 2034

What are the key factors driving the demand for gluten intolerance treatment?

Growing prevalence of celiac diseases and increase in awareness regarding early diagnosis

Which gluten intolerance treatment indication segment held the largest share in 2023?

Celiac disease segment accounted for the largest share in 2023

Which region dominated the global gluten intolerance treatment landscape in 2023?

North America was the dominant region in 2023

Who are the key gluten intolerance treatment manufacturers?

Precigen ActoBio, Calypso Biotech SA, Alvine Pharmaceuticals, Inc., ImmusanT, Artielle ImmunoTherapeutics, FunZyme Biotechnologies, Innovative BioPharma, AMYRA Biotech AG, Vactech Composites Pvt. Ltd., Alba Therapeutics Corporation, PvP Biologics, Inc., and Others

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Gluten Intolerance Treatment Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Definition

        4.1.2. Industry Evolution/Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Gluten Intolerance Treatment Market Analysis and Forecast, 2020-2034

5. Key Insights

    5.1. Pipeline Analysis

    5.2. Key Product /Brand Analysis

    5.3. Key Mergers & Acquisitions

    5.4. COVID-19 Pandemic Impact on Industry

6. Global Gluten Intolerance Treatment Market Analysis and Forecast, by Drug Type

    6.1. Introduction & Definition

    6.2. Key Findings/Developments

    6.3. Market Value Forecast, by Drug Type, 2020-2034

        6.3.1. Antihistamines

        6.3.2. Epinephrine

    6.4. Market Attractiveness Analysis, by Drug Type

7. Global Gluten Intolerance Treatment Market Analysis and Forecast, by Indication

    7.1. Introduction & Definition

    7.2. Key Findings/Developments

    7.3. Market Value Forecast, by Indication, 2020-2034

        7.3.1. Celiac Disease

        7.3.2. Dermatitis Herpetiformis

        7.3.3. Depression

        7.3.4. Gluten Ataxia

    7.4. Market Attractiveness Analysis, by Indication

8. Global Gluten Intolerance Treatment Market Analysis and Forecast, by Distribution Channel

    8.1. Introduction & Definition

    8.2. Key Findings/Developments

    8.3. Market Value Forecast, by Distribution Channel, 2020-2034

        8.3.1. Hospital Pharmacy

        8.3.2. Retail Pharmacy

        8.3.3. Online Pharmacy

    8.4. Market Attractiveness Analysis, by Distribution Channel

9. Global Gluten Intolerance Treatment Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Market Value Forecast, by Region, 2020-2034

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Market Attractiveness Analysis, by Region

10. North America Gluten Intolerance Treatment Market Analysis and Forecast

    10.1. Introduction

    10.2. Key Findings

    10.3. Market Value Forecast, by Drug Type, 2020-2034

        10.3.1. Antihistamines

        10.3.2. Epinephrine

    10.4. Market Value Forecast, by Indication, 2020-2034

        10.4.1. Celiac Disease

        10.4.2. Dermatitis Herpetiformis

        10.4.3. Depression

        10.4.4. Gluten Ataxia

    10.5. Market Value Forecast, by Distribution Channel, 2020-2034

        10.5.1. Hospital Pharmacy

        10.5.2. Retail Pharmacy

        10.5.3. Online Pharmacy

    10.6. Market Value Forecast, by Country, 2020-2034

        10.6.1. U.S.

        10.6.2. Canada

    10.7. Market Attractiveness Analysis

        10.7.1. By Drug Type

        10.7.2. By Indication

        10.7.3. By Distribution Channel

        10.7.4. By Country

11. Europe Gluten Intolerance Treatment Market Analysis and Forecast

    11.1. Introduction

    11.2. Key Findings

    11.3. Market Value Forecast, by Drug Type, 2020-2034

        11.3.1. Antihistamines

        11.3.2. Epinephrine

    11.4. Market Value Forecast, by Indication, 2020-2034

        11.4.1. Celiac Disease

        11.4.2. Dermatitis Herpetiformis

        11.4.3. Depression

        11.4.4. Gluten Ataxia

    11.5. Market Value Forecast, by Distribution Channel, 2020-2034

        11.5.1. Hospital Pharmacy

        11.5.2. Retail Pharmacy

        11.5.3. Online Pharmacy

    11.6. Market Value Forecast, by Country/Sub-region, 2020-2034

        11.6.1. Germany

        11.6.2. U.K.

        11.6.3. France

        11.6.4. Italy

        11.6.5. Spain

        11.6.6. Rest of Europe

    11.7. Market Attractiveness Analysis

        11.7.1. By Drug Type

        11.7.2. By Indication

        11.7.3. By Distribution Channel

        11.7.4. By Country/Sub-region

12. Asia Pacific Gluten Intolerance Treatment Market Analysis and Forecast

    12.1. Introduction

    12.2. Key Findings

    12.3. Market Value Forecast, by Drug Type, 2020-2034

        12.3.1. Antihistamines

        12.3.2. Epinephrine

    12.4. Market Value Forecast, by Indication, 2020-2034

        12.4.1. Celiac Disease

        12.4.2. Dermatitis Herpetiformis

        12.4.3. Depression

        12.4.4. Gluten Ataxia

    12.5. Market Value Forecast, by Distribution Channel, 2020-2034

        12.5.1. Hospital Pharmacy

        12.5.2. Retail Pharmacy

        12.5.3. Online Pharmacy

    12.6. Market Value Forecast, by Country/Sub-region, 2020-2034

        12.6.1. China

        12.6.2. Japan

        12.6.3. India

        12.6.4. Australia & New Zealand

        12.6.5. Rest of Asia Pacific

    12.7. Market Attractiveness Analysis

        12.7.1. By Drug Type

        12.7.2. By Indication

        12.7.3. By Distribution Channel

        12.7.4. By Country/Sub-region

13. Latin America Gluten Intolerance Treatment Market Analysis and Forecast

    13.1. Introduction

    13.2. Key Findings

    13.3. Market Value Forecast, by Drug Type, 2020-2034

        13.3.1. Antihistamines

        13.3.2. Epinephrine

    13.4. Market Value Forecast, by Indication, 2020-2034

        13.4.1. Celiac Disease

        13.4.2. Dermatitis Herpetiformis

        13.4.3. Depression

        13.4.4. Gluten Ataxia

    13.5. Market Value Forecast, by Distribution Channel, 2020-2034

        13.5.1. Hospital Pharmacy

        13.5.2. Retail Pharmacy

        13.5.3. Online Pharmacy

    13.6. Market Value Forecast, by Country/Sub-region, 2020-2034

        13.6.1. Brazil

        13.6.2. Mexico

        13.6.3. Rest of Latin America

    13.7. Market Attractiveness Analysis

        13.7.1. By Drug Type

        13.7.2. By Indication

        13.7.3. By Distribution Channel

        13.7.4. By Country/Sub-region

14. Middle East & Africa Gluten Intolerance Treatment Market Analysis and Forecast

    14.1. Introduction

    14.2. Key Findings

    14.3. Market Value Forecast, by Drug Type, 2020-2034

        14.3.1. Antihistamines

        14.3.2. Epinephrine

    14.4. Market Value Forecast, by Indication, 2020-2034

        14.4.1. Celiac Disease

        14.4.2. Dermatitis Herpetiformis

        14.4.3. Depression

        14.4.4. Gluten Ataxia

    14.5. Market Value Forecast, by Distribution Channel, 2020-2034

        14.5.1. Hospital Pharmacy

        14.5.2. Retail Pharmacy

        14.5.3. Online Pharmacy

    14.6. Market Value Forecast, by Country/Sub-region, 2020-2034

        14.6.1. GCC Countries

        14.6.2. South Africa

        14.6.3. Rest of Middle East & Africa

    14.7. Market Attractiveness Analysis

        14.7.1. By Drug Type

        14.7.2. By Indication

        14.7.3. By Distribution Channel

        14.7.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)

    15.2. Market Share Analysis, by Company (2023)

    15.3. Company Profiles

        15.3.1. Precigen ActoBio

            15.3.1.1. Company Overview

            15.3.1.2. Product Portfolio

            15.3.1.3. SWOT Analysis

            15.3.1.4. Financial Overview

            15.3.1.5. Strategic Overview

        15.3.2. Calypso Biotech SA

            15.3.2.1. Company Overview

            15.3.2.2. Product Portfolio

            15.3.2.3. SWOT Analysis

            15.3.2.4. Financial Overview

            15.3.2.5. Strategic Overview

        15.3.3. Alvine Pharmaceuticals, Inc.

            15.3.3.1. Company Overview

            15.3.3.2. Product Portfolio

            15.3.3.3. SWOT Analysis

            15.3.3.4. Financial Overview

            15.3.3.5. Strategic Overview

        15.3.4. ImmusanT

            15.3.4.1. Company Overview

            15.3.4.2. Product Portfolio

            15.3.4.3. SWOT Analysis

            15.3.4.4. Financial Overview

            15.3.4.5. Strategic Overview

        15.3.5. Artielle ImmunoTherapeutics

            15.3.5.1. Company Overview

            15.3.5.2. Product Portfolio

            15.3.5.3. SWOT Analysis

            15.3.5.4. Financial Overview

            15.3.5.5. Strategic Overview

        15.3.6. FunZyme Biotechnologies

            15.3.6.1. Company Overview

            15.3.6.2. Product Portfolio

            15.3.6.3. SWOT Analysis

            15.3.6.4. Financial Overview

            15.3.6.5. Strategic Overview

        15.3.7. Innovative BioPharma

            15.3.7.1. Company Overview

            15.3.7.2. Product Portfolio

            15.3.7.3. SWOT Analysis

            15.3.7.4. Financial Overview

            15.3.7.5. Strategic Overview

        15.3.8. AMYRA Biotech AG

            15.3.8.1. Company Overview

            15.3.8.2. Product Portfolio

            15.3.8.3. SWOT Analysis

            15.3.8.4. Financial Overview

            15.3.8.5. Strategic Overview

        15.3.9. Vactech Composites Pvt. Ltd.

            15.3.9.1. Company Overview

            15.3.9.2. Product Portfolio

            15.3.9.3. SWOT Analysis

            15.3.9.4. Financial Overview

            15.3.9.5. Strategic Overview

        15.3.10. Alba Therapeutics Corporation

            15.3.10.1. Company Overview

            15.3.10.2. Product Portfolio

            15.3.10.3. SWOT Analysis

            15.3.10.4. Financial Overview

            15.3.10.5. Strategic Overview

        15.3.11. PvP Biologics, Inc.

            15.3.11.1. Company Overview

            15.3.11.2. Product Portfolio

            15.3.11.3. SWOT Analysis

            15.3.11.4. Financial Overview

            15.3.11.5. Strategic Overview

        15.3.12. Others

            15.3.12.1. Company Overview

            15.3.12.2. Product Portfolio

            15.3.12.3. SWOT Analysis

            15.3.12.4. Financial Overview

            15.3.12.5. Strategic Overview

List of Tables

Table 01: Global Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Drug Type, 2020-2034

Table 02: Global Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Indication, 2020-2034

Table 03: Global Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034

Table 04: Global Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Region, 2020-2034

Table 05: North America Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Country, 2020-2034

Table 06: North America Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Drug Type, 2020-2034

Table 07: North America Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Indication, 2020-2034

Table 08: North America Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034

Table 09: Europe Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 10: Europe Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Drug Type, 2020-2034

Table 11: Europe Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Indication, 2020-2034

Table 12: Europe Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034

Table 13: Asia Pacific Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 14: Asia Pacific Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Drug Type, 2020-2034

Table 15: Asia Pacific Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Indication, 2020-2034

Table 16: Asia Pacific Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034

Table 17: Latin America Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 18: Latin America Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Drug Type, 2020-2034

Table 19: Latin America Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Indication, 2020-2034

Table 20: Latin America Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034

Table 21: Middle East & Africa Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 22: Middle East & Africa Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Drug Type, 2020-2034

Table 23: Middle East & Africa Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Indication, 2020-2034

Table 24: Middle East & Africa Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034

List of Figures

Figure 01: Global Gluten Intolerance Treatment Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2034

Figure 02: Global Gluten Intolerance Treatment Market Revenue (US$ Mn), by Drug Type, 2023

Figure 03: Global Gluten Intolerance Treatment Market Value Share, by Drug Type, 2023

Figure 04: Global Gluten Intolerance Treatment Market Revenue (US$ Mn), by Indication, 2023

Figure 05: Global Gluten Intolerance Treatment Market Value Share, by Indication, 2023

Figure 06: Global Gluten Intolerance Treatment Market Revenue (US$ Mn), by Distribution Channel, 2023

Figure 07: Global Gluten Intolerance Treatment Market Value Share, by Distribution Channel, 2023

Figure 08: Global Gluten Intolerance Treatment Market Value Share, by Region, 2023

Figure 09: Global Gluten Intolerance Treatment Market Value (US$ Mn) Forecast, 2020-2034

Figure 10: Global Gluten Intolerance Treatment Market Value Share Analysis, by Drug Type, 2023 and 2034

Figure 11: Global Gluten Intolerance Treatment Market Attractiveness Analysis, by Region, 2024-2034

Figure 12: Global Gluten Intolerance Treatment Market Value Share Analysis, by Indication, 2023 and 2034

Figure 13: Global Gluten Intolerance Treatment Market Attractiveness Analysis, by Indication, 2024-2034

Figure 14: Gluten Intolerance Treatment Market Value Share Analysis, by Distribution Channel, 2023 and 2034

Figure 15: Global Gluten Intolerance Treatment Market Attractiveness Analysis, by Distribution Channel, 2024-2034

Figure 16: Global Gluten Intolerance Treatment Market Value Share Analysis, by Region, 2023 and 2034

Figure 17: Global Gluten Intolerance Treatment Market Attractiveness Analysis, by Region, 2024-2034

Figure 18: North America Gluten Intolerance Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 19: North America Gluten Intolerance Treatment Market Attractiveness Analysis, by Country, 2024-2034

Figure 20: North America Gluten Intolerance Treatment Market Value Share Analysis, by Country, 2023 and 2034

Figure 21: North America Gluten Intolerance Treatment Market Value Share Analysis, by Drug Type, 2023 and 2034

Figure 22: North America Gluten Intolerance Treatment Market Value Share Analysis, by Indication, 2023 and 2034

Figure 23: North America Gluten Intolerance Treatment Market Value Share Analysis, by Distribution Channel, 2023 and 2034

Figure 24: North America Gluten Intolerance Treatment Market Attractiveness Analysis, by Region, 2024-2034

Figure 25: North America Gluten Intolerance Treatment Market Attractiveness Analysis, by Indication, 2024-2034

Figure 26: North America Gluten Intolerance Treatment Market Attractiveness Analysis, by Distribution Channel, 2024-2034

Figure 27: Europe Gluten Intolerance Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 28: Europe Gluten Intolerance Treatment Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 29: Europe Gluten Intolerance Treatment Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 30: Europe Gluten Intolerance Treatment Market Value Share Analysis, by Drug Type, 2023 and 2034

Figure 31: Europe Gluten Intolerance Treatment Market Value Share Analysis, by Indication, 2023 and 2034

Figure 32: Europe Gluten Intolerance Treatment Market Value Share Analysis, by Distribution Channel, 2023 and 2034

Figure 33: Europe Gluten Intolerance Treatment Market Attractiveness Analysis, by Region, 2024-2034

Figure 34: Europe Gluten Intolerance Treatment Market Attractiveness Analysis, by Indication, 2024-2034

Figure 35: Europe Gluten Intolerance Treatment Market Attractiveness Analysis, by Distribution Channel, 2024-2034

Figure 36: Asia Pacific Gluten Intolerance Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 37: Asia Pacific Gluten Intolerance Treatment Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 38: Asia Pacific Gluten Intolerance Treatment Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 39: Asia Pacific Gluten Intolerance Treatment Market Value Share Analysis, by Drug Type, 2023 and 2034

Figure 40: Asia Pacific Gluten Intolerance Treatment Market Value Share Analysis, by Indication, 2023 and 2034

Figure 41: Asia Pacific Gluten Intolerance Treatment Market Value Share Analysis, by Distribution Channel, 2023 and 2034

Figure 42: Asia Pacific Gluten Intolerance Treatment Market Attractiveness Analysis, by Region, 2024-2034

Figure 43: Asia Pacific Gluten Intolerance Treatment Market Attractiveness Analysis, by Indication, 2024-2034

Figure 44: Asia Pacific Gluten Intolerance Treatment Market Attractiveness Analysis, by Distribution Channel, 2024-2034

Figure 45: Latin America Gluten Intolerance Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 46: Latin America Gluten Intolerance Treatment Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 47: Latin America Gluten Intolerance Treatment Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 48: Latin America Gluten Intolerance Treatment Market Value Share Analysis, by Drug Type, 2023 and 2034

Figure 49: Latin America Gluten Intolerance Treatment Market Value Share Analysis, by Indication, 2023 and 2034

Figure 50: Latin America Gluten Intolerance Treatment Market Value Share Analysis, by Distribution Channel, 2023 and 2034

Figure 51: Latin America Gluten Intolerance Treatment Market Attractiveness Analysis, by Region, 2024-2034

Figure 52: Latin America Gluten Intolerance Treatment Market Attractiveness Analysis, by Indication, 2024-2034

Figure 53: Latin America Gluten Intolerance Treatment Market Attractiveness Analysis, by Distribution Channel, 2024-2034

Figure 54: Middle East & Africa Gluten Intolerance Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 55: Middle East & Africa Gluten Intolerance Treatment Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 56: Middle East & Africa Gluten Intolerance Treatment Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 57: Middle East & Africa Gluten Intolerance Treatment Market Value Share Analysis, by Drug Type, 2023 and 2034

Figure 58: Middle East & Africa Gluten Intolerance Treatment Market Value Share Analysis, by Indication, 2023 and 2034

Figure 59: Middle East & Africa Gluten Intolerance Treatment Market Value Share Analysis, by Distribution Channel, 2023 and 2034

Figure 60: Middle East & Africa Gluten Intolerance Treatment Market Attractiveness Analysis, by Region, 2024-2034

Figure 61: Middle East & Africa Gluten Intolerance Treatment Market Attractiveness Analysis, by Indication, 2024-2034

Figure 62: Middle East & Africa Gluten Intolerance Treatment Market Attractiveness Analysis, by Distribution Channel, 2024-2034

Copyright © Transparency Market Research, Inc. All Rights reserved